VANCOUVER, British Columbia, Oct.  24, 2022  (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) is pleased to announce that its wholly owned subsidiary, HYTN Cannabis Inc., has entered into a sales, distribution and marketing agreement (the “Agreement”) with Rose LifeScience Inc. (Rose ScienceVie) (“Rose”), a leading supplier of cannabis products in Quebec. The Agreement provides a path for HYTN to sell its products, through Rose, to la Société québécoise du cannabis (the “SQDC”) and supports the Company’s goal of delivering its consistent, natural and delicious cannabis products featuring Elevation Technology® to every province and territory in Canada.
HYTN Initiates Sale of Cannabis Products in Quebec Through Agreement With Rose
HYTN Initiates Sale of Cannabis Products in Quebec Through Agreement With Rose --  HYTN Innovations Inc. (“HYTN” or the “Company”) (CSE: HYTN) is pleased to announce that its wholly owned subsidiary, HYTN Cannabis Inc., has entered into a sales, distribution and marketing agreement (the “Agreement”) with Rose LifeScience Inc. (Rose ScienceVie) (“Rose”), a leading supplier of cannabis products in Quebec. The Agreement provides a path for HYTN to sell its products, through Rose, to la Société québécoise du cannabis (the “SQDC”) and supports the Company’s goal of delivering its consistent, natural and delicious cannabis products featuring Elevation Technology® to every province and territory in Canada.